Scott K. Sherman

ORCID: 0000-0003-4903-0422
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Pancreatic and Hepatic Oncology Research
  • Gastrointestinal Tumor Research and Treatment
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Intraperitoneal and Appendiceal Malignancies
  • Colorectal Cancer Surgical Treatments
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Treatments and Studies
  • Appendicitis Diagnosis and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Ovarian cancer diagnosis and treatment
  • Gastric Cancer Management and Outcomes
  • Colorectal and Anal Carcinomas
  • Colorectal Cancer Screening and Detection
  • Receptor Mechanisms and Signaling
  • Enhanced Recovery After Surgery
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Health Systems, Economic Evaluations, Quality of Life
  • Fibroblast Growth Factor Research
  • PI3K/AKT/mTOR signaling in cancer
  • Pelvic and Acetabular Injuries
  • Parathyroid Disorders and Treatments

University of Iowa
2013-2024

University of Iowa Hospitals and Clinics
2013-2024

University of Iowa Holden Comprehensive Cancer Center
2024

University of Chicago
2018-2022

Virginia Commonwealth University
2015

Virginia Commonwealth University Medical Center
2015

Foundation for the National Institutes of Health
2014

American Society of Colon and Rectal Surgeons
2014

Unregulated drug prices increase cancer therapy costs. After induction chemotherapy, patients with metastatic colon can receive maintenance capecitabine and bevacizumab based on improved progression-free survival, but whether this treatment's cost justifies its benefits has not been evaluated in the United States.This study sought to determine influence of cost-effectiveness from a Medicare payer's perspective.The incremental was determined Markov model using quality-of-life penalty outcomes...

10.1001/jamaoncol.2018.5070 article EN JAMA Oncology 2018-11-29

Critical Care Evaluation| November 01 2015 Validity and Sensitivity of 6 Pain Scales in Critically Ill, Intubated Adults CE Article Mamoona Arif Rahu, RN, PhD, CCRN; CCRN Rahu is a clinical nurse specialist the surgical trauma intensive care unit, Virginia Commonwealth University Medical Center, Richmond, Virginia. Mary Jo Grap nursing alumni endowed professor Adult Health Nursing Systems, School Nursing, University, Pam Ferguson II, Patty Joseph III coordinator, Sarah Sherman practitioner...

10.4037/ajcc2015832 article EN American Journal of Critical Care 2015-10-31

Mechanisms of neuroendocrine tumor (NET) proliferation are poorly understood, and therapies that effectively control NET progression metastatic disease limited. We found amplification a putative oncogene, RABL6A, in primary human pancreatic NETs (PNET) correlated with high-level RABL6A protein expression. Consistent those results, stable silencing cultured BON-1 PNET cells revealed it is essential for their survival. Cells lacking predominantly arrested G1 phase moderate mitotic block....

10.1158/0008-5472.can-13-3742 article EN Cancer Research 2014-10-02

The unique surgical challenges of proctectomy may be amplified in obese patients. We examined outcomes a large, diverse sample patients undergoing proctectomy.The purpose this work was to determine whether increased BMI is associated with complications proctectomy.This retrospective review.The study uses the American College Surgeons National Surgical Quality Improvement Program database (2010 and 2011).Patients included were those nonemergent proctectomy, excluding rectal prolapse cases....

10.1097/dcr.0000000000000051 article EN Diseases of the Colon & Rectum 2014-04-07

10.1016/j.cpsurg.2020.100823 article Current Problems in Surgery 2020-05-15
Coming Soon ...